Your Morning Coffee Might Be Protecting Your Liver

If you start your morning with a cup of coffee, here is some news worth savoring. A large new study published in Clinical Gastroenterology and Hepatology suggests that drinking coffee regularly may offer meaningful protection against serious liver disease, and the findings hold up across multiple types of evidence, including medical imaging, blood protein analysis and long-term health outcomes tracked over more than a decade.

Coffee is one of the most widely consumed beverages in the world and has long been studied for its potential to protect against chronic liver disease, including cirrhosis and liver cancer. While previous research has suggested a link between regular coffee consumption and better liver health, many earlier studies had limitations and did not account for important variables like coffee type, the use of sugar or artificial sweeteners, or individual differences in metabolism and genetics.

Coffee contains hundreds of biologically active compounds, including caffeine, chlorogenic acids and diterpenes, that may reduce inflammation, oxidative stress and liver scarring, though researchers have not yet pinpointed exactly which compounds or biological pathways are responsible for the protective effect.

In the current study, a team of investigators analyzed data from nearly 355,000 participants in the UK Biobank, one of the largest health databases in the world, following them for a median of 13 years. None of the participants had cirrhosis or liver cancer at the start of the study. Over the follow-up period, they tracked who developed cirrhosis or hepatocellular carcinoma, which is the most common form of liver cancer, and who died from liver-related causes.

The results were striking. Compared with people who did not drink coffee, those who drank five or more cups per day had a 32% lower risk of developing cirrhosis, a 47% lower risk of developing liver cancer and a 42% lower risk of dying from liver-related causes. Importantly, the protective effect was not limited to heavy coffee drinkers. Even moderate consumption showed meaningful benefits, with the protection increasing gradually as intake went up.

One of the most reassuring findings was that the type of coffee did not appear to matter significantly. Both caffeinated and decaffeinated coffee were associated with similar liver benefits, suggesting that caffeine alone is not the active ingredient driving the protection. Adding sugar or artificial sweeteners did not eliminate the benefit either, though the researchers noted that people who used additives showed slightly higher levels of a marker associated with liver inflammation, a finding worth keeping in mind.

The study went beyond just tracking diagnoses. A subset of participants underwent liver imaging, which showed that higher coffee intake was associated with lower levels of liver fat, lower liver iron and less fibroinflammation, a marker of scarring and inflammation in the liver. Investigators also analyzed proteins in the blood and found that coffee drinkers had higher levels of proteins associated with healthy liver function and lower levels of proteins linked to liver scarring and immune activation.

The team concluded that these findings, taken together, support moderate consumption of unsweetened coffee as a simple, accessible strategy for liver disease prevention. While coffee is not a treatment for existing liver disease and should not replace medical care, the evidence suggests that for most people, a daily coffee habit may be doing more good than they realize.

As always, individual health circumstances vary, and anyone with concerns about their liver health should speak with their physician.